The findings in the preliminary study were significant -- median survival among advanced lung cancer patients doubled in the population who received the shot.
Bringing together hospital and healthcare leaders for the last 17 years. If you are a healthcare leader looking to network with other healthcare & hospital leaders, we hope to see you on the road in 2025!
